Reslizumab Treatment: Dosage, Side Effects, and Uses Explained

Summary of Key Points

Reslizumab is a prescription medication primarily used to manage asthma and other conditions associated with elevated levels of eosinophils, a type of white blood cell. This biologic therapy works by targeting and reducing eosinophils, which play a significant role in inflammation within the body. Administered via intravenous (IV) infusion, Reslizumab is typically prescribed when other treatments have not been effective. It is essential to consult your healthcare provider before starting or modifying any medication regimen.

Names of the Medication

US Brand Name: Cinqair

Generic Name: Reslizumab

The generic name, Reslizumab, refers to the active ingredient, while the brand name, Cinqair, is the name assigned by the manufacturer.

Pharmacologic Category

Monoclonal Antibody (Anti-IL-5)

Reslizumab belongs to the pharmacologic category of monoclonal antibodies. Specifically, it is an anti-IL-5 therapy, meaning it targets interleukin-5 (IL-5), a protein that plays a critical role in eosinophil-driven inflammation. This targeted mechanism makes Reslizumab an effective treatment for asthma and other conditions related to elevated eosinophil levels.

Reslizumab Dosage

Reslizumab is prescribed for various conditions in adults. Below are the recommended dosages for each condition. Always consult your healthcare provider before making any changes to your medication regimen. If needed, you can schedule a telemedicine appointment with one of our doctors for further guidance.

Asthma (Eosinophilic Type)

Dosage: 3 mg/kg administered by intravenous (IV) infusion every 4 weeks. Treatment is typically ongoing and long-term, depending on the patient’s response.

Eosinophilic Esophagitis

Dosage: Off-label use. Consult your healthcare provider for specific dosing recommendations.

Chronic Rhinosinusitis with Nasal Polyps

Dosage: Off-label use. Consult your healthcare provider for specific dosing recommendations.

Allergic Rhinitis

Dosage: Off-label use. Consult your healthcare provider for specific dosing recommendations.

Atopic Dermatitis

Dosage: Off-label use. Consult your healthcare provider for specific dosing recommendations.

Chronic Obstructive Pulmonary Disease (COPD)

Dosage: Off-label use. Consult your healthcare provider for specific dosing recommendations.

Hypereosinophilia

Dosage: 3 mg/kg administered by intravenous (IV) infusion every 4 weeks. The duration of treatment depends on the patient’s response and the severity of the condition.

Systemic Lupus Erythematosus

Dosage: Off-label use. Consult your healthcare provider for specific dosing recommendations.

Ulcerative Colitis

Dosage: Off-label use. Consult your healthcare provider for specific dosing recommendations.

Crohn’s Disease

Dosage: Off-label use. Consult your healthcare provider for specific dosing recommendations.

Dosage Forms and Strengths

Solution for Intravenous Infusion: 100 mg/10 mL (10 mg/mL)

Reslizumab Injection Administration Instructions

Reslizumab is administered by a healthcare professional through an intravenous (IV) infusion. The infusion process typically takes between 20 and 50 minutes. It is crucial to follow your healthcare provider’s instructions regarding the timing and frequency of your infusions. Do not attempt to administer this medication on your own. If you have any questions about your treatment, our telemedicine providers are available to assist you.

Reslizumab Side Effects and Adverse Reactions

As with all medications, Reslizumab may cause side effects. It is important to be aware of these potential risks and discuss them with your healthcare provider. Below are some of the most common and serious side effects associated with Reslizumab treatment:

Common Side Effects

These side effects occur in more than 1 in 10 patients:

1. Throat pain
2. Muscle pain

Less Common Side Effects

These side effects occur in less than 1 in 10 patients:

1. Fatigue
2. Increased risk of infection

Serious Side Effects

These side effects are rare but require immediate medical attention:

1. Severe allergic reactions (anaphylaxis)
2. Chest pain
3. Difficulty breathing

If you experience any of these side effects, especially severe allergic reactions, contact your healthcare provider immediately. For concerns about side effects, our telemedicine team is available to help you understand your symptoms and guide you on the next steps.

Contraindications of Reslizumab Treatment

A contraindication refers to a specific condition or circumstance in which a medication, such as **Reslizumab**, should not be used because it may pose a risk to the patient. Recognizing these contraindications is crucial to ensuring safe and effective treatment with **Reslizumab**.

Hypersensitivity to Reslizumab: Patients who have previously experienced an allergic reaction to **Reslizumab** or any of its ingredients should avoid this medication. Allergic reactions can manifest as severe symptoms, including swelling, difficulty breathing, or, in rare cases, life-threatening anaphylaxis.

Acute Asthma Exacerbation: **Reslizumab** is not designed to treat sudden asthma attacks. If you experience a rapid worsening of asthma symptoms, seek immediate medical care and use a fast-acting rescue inhaler rather than relying on **Reslizumab** for relief.

Parasitic Infections: Individuals with known parasitic infections should approach **Reslizumab treatment** with caution. This medication may influence the immune system, potentially impairing the body’s ability to fight certain parasites and exacerbating the infection.

Drug-to-Drug Interactions with Reslizumab

**Reslizumab** may interact with other medications, which could either reduce its effectiveness or increase the likelihood of side effects. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and dietary supplements, before beginning **Reslizumab treatment**.

Live Vaccines: Receiving live vaccines while undergoing **Reslizumab treatment** may elevate the risk of infection. Examples of live vaccines include the MMR (measles, mumps, and rubella) vaccine and the varicella (chickenpox) vaccine.

Immunosuppressants: Using **Reslizumab** in combination with immunosuppressive medications, such as corticosteroids (e.g., prednisone), may further suppress immune system activity, increasing the risk of infections.

Monoclonal Antibodies: Other monoclonal antibody treatments, such as omalizumab (Xolair) or dupilumab (Dupixent), may interact with **Reslizumab**. Since these biologic therapies for asthma have similar mechanisms of action, combining them could heighten the risk of side effects.

Reslizumab and Pregnancy: What You Need to Know

Is it safe to take Reslizumab during pregnancy?

The safety of **Reslizumab** during pregnancy has not been conclusively determined. While animal studies have not shown harm to the fetus, there is limited data on its effects in human pregnancies. If you are pregnant or planning to become pregnant, consult your healthcare provider to carefully evaluate the potential risks and benefits of **Reslizumab treatment**. Your provider can help you weigh the risks of untreated severe asthma or other conditions against the possible effects of the medication on your pregnancy.

Reslizumab While Breastfeeding: Safety Considerations

Is it safe to take Reslizumab while breastfeeding?

There is limited information on whether **Reslizumab** is excreted in breast milk. Due to its large protein structure, it is unlikely to be absorbed in significant amounts by a breastfeeding infant. However, because data is scarce, it is essential to consult your healthcare provider. They can guide you in deciding whether to continue breastfeeding while undergoing **Reslizumab treatment** or explore alternative options that may better suit your situation.

Estimated Cost of Reslizumab Treatment

The cost of **Reslizumab treatment** can be substantial, particularly for those without insurance coverage. A single dose, typically administered every four weeks, can range from approximately $1,000 to $2,500 when using a GoodRx coupon. This estimate reflects the price of a 30-day supply. For more precise pricing, consult your insurance provider or local pharmacy, as costs may vary based on your coverage plan and location.

Possible Alternatives to Reslizumab Treatment

If Reslizumab is not the right treatment for you, there are several alternatives worth considering. It’s essential to consult your healthcare provider before making any changes to your treatment plan. You can also schedule a telemedicine appointment with one of our providers to explore these options in greater detail.

Asthma

For asthma, alternatives to Reslizumab include inhaled corticosteroids, such as fluticasone, leukotriene modifiers like montelukast, and other biologics, such as omalizumab (Xolair). Additionally, lifestyle modifications—such as avoiding known asthma triggers and maintaining a healthy weight—can play a significant role in managing symptoms effectively.

Eosinophilic Esophagitis

In the case of eosinophilic esophagitis, treatment options include proton pump inhibitors (e.g., omeprazole), swallowed corticosteroids like fluticasone, and dietary adjustments, such as eliminating specific food allergens. These alternatives may be appropriate if Reslizumab is not suitable for your condition.

Chronic Rhinosinusitis with Nasal Polyps

Managing chronic rhinosinusitis with nasal polyps often involves nasal corticosteroids, such as mometasone, saline nasal irrigation, or, in some cases, surgical removal of polyps. Biologic therapies like dupilumab (Dupixent) may also provide significant relief for some patients.

Allergic Rhinitis

For allergic rhinitis, common alternatives include antihistamines, such as loratadine, nasal corticosteroids like fluticasone, and allergy immunotherapy (commonly known as allergy shots). Additionally, minimizing exposure to allergens can help alleviate symptoms and improve overall comfort.

Atopic Dermatitis

When managing atopic dermatitis, alternatives include topical corticosteroids, such as hydrocortisone, calcineurin inhibitors like tacrolimus, and biologics such as dupilumab (Dupixent). Regularly moisturizing the skin and avoiding irritants can further enhance symptom control and improve skin health.

Chronic Obstructive Pulmonary Disease (COPD)

Treatment options for COPD include bronchodilators, such as albuterol, inhaled corticosteroids like budesonide, and pulmonary rehabilitation programs. Lifestyle changes, including quitting smoking and staying physically active, are also critical components of effective COPD management.

Hypereosinophilia

For hypereosinophilia, alternatives include corticosteroids, such as prednisone, and biologics like mepolizumab (Nucala). Identifying and addressing the underlying cause of hypereosinophilia is a vital part of the treatment process.

Systemic Lupus Erythematosus

Treatment options for systemic lupus erythematosus include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and immunosuppressants, such as methotrexate. Lifestyle adjustments, including sun protection and stress management, can also help reduce symptom severity and improve quality of life.

Ulcerative Colitis

For ulcerative colitis, alternatives include aminosalicylates, such as mesalamine, corticosteroids, and biologics like infliximab (Remicade). Incorporating dietary changes and stress management techniques can further help reduce flare-ups and enhance overall well-being.

Crohn’s Disease

Treatment options for Crohn’s disease include corticosteroids, immunosuppressants like azathioprine, and biologics such as adalimumab (Humira). Adopting a low-fiber diet and avoiding trigger foods can also aid in managing symptoms more effectively.

Recent Updates on Reslizumab Research

Recent studies continue to investigate the potential of Reslizumab for conditions beyond severe eosinophilic asthma. Researchers are exploring its use in other eosinophilic disorders, such as eosinophilic esophagitis and hypereosinophilic syndrome. Additionally, ongoing studies are examining the long-term safety and effectiveness of Reslizumab, particularly when combined with other biologic therapies. While these findings are encouraging, further research is needed to confirm its benefits in these areas. To stay informed about the latest advancements in Reslizumab treatment, consult your healthcare provider regularly.

James Kingsley

Learn More